Saltar al contenido
Merck

Biotin-responsive basal ganglia disease: case report and review of the literature.

Neuropediatrics (2009-03-19)
T I El-Hajj, P E Karam, M A Mikati
RESUMEN

Biotin-responsive basal ganglia disease is a rare entity of which 10 cases have been reported in the literature. We report a case of biotin-responsive basal ganglia disease with similarities and differences compared to the previously reported cases by Ozand et al. Our case presented much earlier, was milder and responded better to lower doses of biotin, compared to the cases reported previously. Since our case showed differences with those in the literature, it might represent a new entity or a milder form of the same entity.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Biotina, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99%
USP
Biotina, United States Pharmacopeia (USP) Reference Standard
SAFC
Biotina
Sigma-Aldrich
Biotina, ≥99.0% (T)
Supelco
Biotina, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Biotina, meets USP testing specifications
Sigma-Aldrich
Biotina, tested according to Ph. Eur.
Supelco
Biotina, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Biotina, European Pharmacopoeia (EP) Reference Standard